NM_001081.4(CUBN):c.2792-5_2795del AND multiple conditions

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: Jan 5, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV005039766.1

Allele description [Variation Report for NM_001081.4(CUBN):c.2792-5_2795del]

NM_001081.4(CUBN):c.2792-5_2795del

Gene:

CUBN:cubilin [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

10p13

Genomic location:

Preferred name:

NM_001081.4(CUBN):c.2792-5_2795del

HGVS:

NC_000010.11:g.17068277_17068285del
NG_008967.1:g.66533_66541del
NM_001081.4:c.2792-5_2795delMANE SELECT
LRG_540:g.66533_66541del
NC_000010.10:g.17110276_17110284del

Molecular consequence:

NM_001081.4:c.2792-5_2795del - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:: Imerslund-Grasbeck syndrome type 1 (IGS1)
Synonyms:: Megaloblastic anemia 1, Finnish type; Imerslund-Gräsbeck syndrome 1
Identifiers:: MONDO: MONDO:0100156; MedGen: C4016819; OMIM: 261100

Name:: Proteinuria, chronic benign
Identifiers:: MONDO: MONDO:0030042; MedGen: C5394384; OMIM: 618884

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV005670856	Fulgent Genetics, Fulgent Genetics	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely pathogenic (Jan 5, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV005670856

Fulgent Genetics, Fulgent Genetics

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely pathogenic
(Jan 5, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV005670856.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Apr 7, 2025

ClinVar

Relating variation to medicine